by Kazeem Olalekan MRPharmS I took my daughter to the optician recently and it got me thinking: What an amazing thing: vision! We all need it and all the better if it is a good one. In October last year, I wrote a blog about the 2020
Read more →by Kazeem Olalekan MRPharmS If you follow our blog, you will know that we are passionate about apps (you know..iphone (OS), android and possibly others – I know Microsoft is working very hard to narrow the gap on its rivals – so when we get our hands
Read more →by Kazeem Olalekan MRPharmS I cannot help but notice, with concern, the latest news item by in which Boots the Chemist is to offer ‘3 for 2’ mix and match promotion across its entire healthcare range this week (link). Clearly the customer will welcome an opportunity to pay
Read more →by Kazeem Olalekan MRPharmS In August a number of communications on medicines safety were sent out to healthcare professionals via the MHRA. If you missed any of it then here are the summary. Full details are available on the MHRA website. Number 1: Number 2: Number 3:
Read more →by Kazeem Olalekan MRPharmS This July we have posted our 6th Case Study. We are quite proud about this one. Kazeem conducted an interview with Sue Gough, a Critical Evaluation Pharmacist at University Hospitals Southampton NHS Foundation Trust. It provides an insight into what these breeds of
Read more →by Kazeem Olalekan MRPharmS I was delighted by the news that the National Paediatric Surgery Reviews has opted for option B which means that University Hospital Southampton NHS Foundation Trust (UHSFT) in partnership with Oxford Radcliffe Hospitals NHS Trust will continue to deliver first class quality service
Read more →by Kazeem Olalekan MRPharmS The latest update to MUR requirements (1) which applied from the 1st of July is refreshing. If I was commissioning the service for the first time, this is what it might look like. Nonetheless, evolution is not a bad thing. The
Read more →by Kazeem Olalekan Clearly I am excitable. When I learnt of the new iphone and Android app from the nice folks at NICE, then you know what is coming. Hee Heee Heeeeeeeeeeeeeeeeeeeeee Haaaaaaaaaaaah! I’ll tell you why. I spent my top dollar about a year ago on
Read more →by Kazeem Olalekan Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately
Read more →by Kazeem Olalekan MRPharmS The recent acquisition of 45% stake in Boots the Chemist by US Firm, Walgreen could be viewed as another good example of the special relationship between the US and the UK. It has been reported that the two companies have very little overlap.
Read more →by Kazeem Olalekan MRPharmS The final report on the transfer of information about medicine when patients move between care setting has been published. It makes for an interesting read. The main recommendations are: The report quoted an audit conducted in 2010 across 50 acute trusts
Read more →by Kazeem Olalekan The Royal Pharmaceutical Society of Great Britain has issued advice to pharmacist on how to deal with requests for emergency supplies of regular medicines. The doctors go on strike this Thursday (21st of June). The key advise are:
Read more →by Kazeem Olalekan Following from the recently completed election onto the National Pharmacy Board in England, Wales and Scotland; bookapharmacist.com is happy to note that this is an election it is proud of. Everyone is a winner: elected or not. We are releasing a YouTube video of
Read more →by Kazeem Olalekan The publication of the final report into the PIP debacle, by the NHS Medical Director, should signal the ‘silence of the pips’. The report is making it clear that: This report should at least silence the pips and bring reassurance to worried patients. The
Read more →by Kazeem Olalekan MRPharmS Cyclizine Lactate Injection 50mg/ 1ml ampoules PL 00156/0096 Martindale Pharmaceuticals Ltd is recalling all remaining unexpired ampoules of the above discontinued product as a precautionary measure. This is due to a GMP concern at a third-party supplier and their own site. It is likely
Read more →